Three Alternative Scenarios of the Future Diagnostics Market: Business-as-Usual, Economic Austerity, Technological Breakthroughs - Which companies will enter the market and which will not survive?

July 2015 | 255 pages | ID: T05D7FCF937EN
Venture Planning Group

Abstracts

This new report is designed to help executives develop effective contingency plans that best accommodate uncertainties ahead. The study objectives include:

• To identify and evaluate emerging markets and technologies that may present unexpected threats or offer opportunities.
• To identify key strategic decisions that will have to be made in the future.
• To enhance corporate ability to develop realistic contingency plans.
• To prepare executives to accommodate radically different operating climates and reduce surprises.
• To challenge accepted perceptions of the future diagnostics market.

This report is an invaluable strategic planning resource for corporate, marketing and R&D executives. The strategic issues explored in the report include:

• How will the future reimbursement changes affect individual market segments?
• Will the industry consolidate, decentralize, or undergo a bimodal transformation?
• What will be the impact on purchasing influences, marketing strategies, joint ventures, mergers, licensing, import and export?
• How will the future technological advances affect the major market segment?
• Which companies will enter the market and which will not survive?

These and other key issues facing the decision-makers are explored in this thought-provoking and multi-faceted portrait of the three possible futures and their strategic implication. We would be glad to answer any questions you might have regarding this informative, comprehensive and insightful market research and technology assessment report, and look forward to your subscription.

Contains 255 pages and 32 tables

Contents

I. INTRODUCTION

II. EXECUTIVE SUMMARY

A. BUSINESS - AS - USUAL SCENARIO

B. ECONOMIC AUSTERITY SCENARIO

C.TECHNOLOGICAL BREAKTHROUGHS SCENARIO

III. CONCLUSIONS AND RECOMMENDATIONS

IV.THE SCENARIOS,  2011 - 20  16

A. BUSINESS - AS - USUAL SCENARIO

  1. Business Environment
    a. Health Care Expenditures
    b. Cost - Consciousness
    c. Reimbursement
    d. Industry Consolidation
    e. Managed Care
     PPOs
     HMOs
    f. Hospitals
    g. Admissions
    h. Length of Stay
    i. Industry Diversification
    j. Physician Demographics
    k. Aging Population
     Chronic Illnesses
     Disease Incidence
     Susceptibility to Iatrogenesis
     Multiple Illness Cases
    l. Laboratory Regulations
    m. The FDA Reform
  2. Outlook for the In Vitro Diagnostics Market
    a. Government Regulations
    b. Centralized Testing
     Hospitals
     Commercial Laboratories
     Blood Banks
     Public Health Laboratories
    c. Decentralized Testing
     Personal Testing
     Physician Offices/Group Practices
     Ancillary Hospital Locations
     ERs
     ORs
     ICUs/CCUs
     Cancer Clinics
     Ambulatory Care Centers
     Surgery Centers
     Nursing Homes
     Birth Centers
  3. Strategic Implications
    a. Testing Patterns
     Test Utilization
     Pre - Admission Testing
     Inpatient Testing
     Outpatient Testing
  4. Market Segments
    a. Chemistry and Immunoassay
     Introduction
     Future Situation
    b. Microbiology and Serology
     Introduction
     Future Situation
    c. Hematology and Flow Cytometry
     Introduction
     Future Situation
    d. Histology and Cytology
     Introduction
     Future Situation
    e. Coagulation
     Introduction
     Future Situation
    f. Urinalysis
     Introduction
     Future Situation
    g. Blood Banking
     Introduction
     Future Situation
  5. Technologies
    a. Genomics
     Introduction
     Future Situation
    b. Proteomics
     Introduction
     Future Situation
    c. DNA Probes
     Introduction
     Future Situation
    d. Biochips/Microarrays
     Introduction
     Future Situation
    e. Monoclonal Antibodies
     Introduction
     Future Situation
    f. Solid Phase Chemistry
     Introduction
     Future Situation
    g. Biosensors
     Introduction
     Future Situation
    h. Automation and Robotics
     Introduction
     Future Situation
    i. Computer - Aided Diagnosis
     Introduction
     Future Situation
  6. The New Marketplace
    a. Purchasing Influences
    b. Marketing Strategies
    c. Joint Ventures, Mergers and Licensing
    d. Import - Export
    e. Potential Market Entrants
    f. Who May Not Survive?

B. ECONOMIC AUSTERITY SCENARIO

  1. Business Environment
    a. Socio - Political Climate
     Cost - Consciousness
     Government Actions
     Three - Tier System
     Health Rationing
     Voucher System
     Health IRA
    b. Hospital Closures
    c. Hospital Utilization
    d. Hospital Reorganization
    e. Physician Regulations
    f. Wellness Programs
    g. Corporate Responses
    h. Academic Research
  2. Outlook for the In Vitro Diagnostics Market
    a. Test Utilization
     Ordering Practices
     Documentation
     Recertification
    b. Technology Regulations
    c. New Laboratory Ventures
    d. Computers
    e. Industrial Medicine
    f. Insurance Companies
    g. Test Volume and Market Size
  3. Strategic Implications
    a. Testing Patterns
     Pre - Admission Testing
     Inpatient Testing
     Outpatient Testing
    b. Market Segments
     Chemistry and Immunoassay
     Microbiology and Serology
     Hematology and Flow Cytometry
     Histology and Cytology
     Coagulation
     Urinalysis
     Blood Banking
    c. Technologies
     Genomics
     Proteomics
     DNA Probes
     Biochips/Microarrays
     Monoclonal Antibodies and Immunoassays
     Automation and Robotics
     Solid Phase Chemistry
     Biosensors
     Computer - Aided Diagnosis
    d. The New Marketplace
     Purchasing Influences
     Marketing Strategies
     Joint Ventures, Mergers and Licensing
     Import - Export
     Potential Market Entrants
     Who May Not Survive?

C. TECHNOLOGICAL BREAKTHROUGHS SCENARIO

  1. Business Environment
    a. Political/Regulatory Climate
    b. R & D Funding
    c. Industry - Government Relationship
    d. Industry - University Ventures
    e. Technological Environment
    f. Testing Decentralization
    g. Health Care Expenditures
    h. Physician Population
    i. Hospital Indicators
  2. Outlook for the In Vitro Diagnostics Market     a. Overview
    b. Genomics
    c. Proteomics
    d. DNA and RNA Probes
    e. Biochips/Microarrays
    f. Monoclonal Antibodies
    g. Immunoassays
    h. Information Technology
    i. Laboratory Automation and Robotics
    j. Solid Phase Chemistry
    k. Biosensors
    l. Holography
    m. Pharmaceuticals
  3. Strategic Implications
    a. Testing Patterns
     Pre - Admission Testing
     Inpatient Testing
     Outpatient Testing
     Test Volume and Market Size
    b. Market Segments
     Chemistry and Immunoassay Microbiology and Serology
     Hematology and Flow Cytometry
     Histology and Cytology
     Coagulation
     Urinalysis
     Blood Banking
    c. The New Marketplace
     Purchasing Influences
     Marketing Strategies
     Joint Ventures, Mergers and Licensing
     Import - Export
     Potential Market Entrants
     Who May Not Survive?

V. APPENDICES: METHODOLOGY

A. The Delphi
B. Cross - Impact Analysis
C. Substitution Modeling

List Of Tables

LIST OF TABLES

Executive Summary Table I: Business - As - Usual Scenario, Growth Areas in Clinical Laboratory Testing,  2011 - 20  16
Executive Summary Table II: Economic Austerity Scenario, Growth Areas in Clinical Laboratory Testing,  2011 - 20  16
Executive Summary Table III: Technological Breakthroughs Scenario, Growth Areas in Clinical Laboratory Testing,  2011 - 20  16
Executive Summary Table IV: Market Size by Location
Executive Summary Table V: Market Size by Laboratory Discipline
Table - 1: Business - As - Usual Scenario, Health Care Costs by Expenditure Type
Table - 2: Business - As - Usual Scenario, HMO and PPO Enrollment
Table - 3: Business - As - Usual Scenario, Selected Hospital Statistics
Table - 4: Business - As - Usual Scenario,Total Population and Physician Demographics
Table - 5: Business - As - Usual Scenario,Test Volume by Location
Table - 6: Business - As - Usual Scenario,Test Distribution by Location
Table - 7: Business - As - Usual Scenario, Market Size by Location
Table - 8: Business - As - Usual Scenario,Typical Pre - Admission Tests
Table - 9: Business - As - Usual Scenario,Test Volume by Laboratory Discipline
Table - 10: Business - As - Usual Scenario, Market Size By Laboratory Discipline
Table - 11: Economic Austerity Scenario, Selected Hospital Statistics
Table - 12: Economic Austerity Scenario, HMO and PPO Enrollment
Table - 13: Economic Austerity Scenario,Total Population and Physician Demographics
Table - 14: Economic Austerity Scenario, Major Categories of Overutilized Tests
Table - 15: Economic Austerity Scenario, Test Volume by Location
Table - 16: Economic Austerity Scenario, Test Distribution by Location
Table - 17: Economic Austerity Scenario, Market Size by Location
Table - 18: Economic Austerity Scenario, Timing Requirements for Selected Laboratory Tests
Table - 19: Economic Austerity Scenario, Test Volume by Laboratory Discipline
Table - 20: Economic Austerity Scenario, Market Size by Laboratory Discipline
Table - 21: Technological Breakthroughs Scenario, HMO and PPO Enrollment
Table - 2  2: Technological Breakthroughs Scenario,Total Population and Physician Demographics
Table - 2  3: Technological Breakthroughs Scenario, Selected Hospital Statistics
Table - 2  4: Technological Breakthroughs Scenario, Test Volume by Location
Table - 2  5: Technological Breakthroughs Scenario, Test Distribution by Location
Table - 2  6: Technological Breakthroughs Scenario, Market Size by Location
Table - 2  7: Technological Breakthroughs Scenario, Test Volume by Laboratory Discipline
Table - 2  8: Technological Breakthroughs Scenario, Market Size by Laboratory Discipline